No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
REGN Regeneron Pharmaceuticals
- 983.800
- -10.150-1.02%
Close May 22 16:00 ET
- 985.020
- +1.220+0.12%
Pre 04:07 ET
108.40BMarket Cap29.05P/E (TTM)
997.870High981.570Low308.65KVolume993.000Open993.950Pre Close304.75MTurnover0.29%Turnover Ratio28.29P/E (Static)110.19MShares998.32552wk High4.02P/B103.91BFloat Cap684.80552wk Low--Dividend TTM105.62MShs Float998.325Historical High--Div YieldTTM1.64%Amplitude4.610Historical Low987.362Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Regeneron Pharmaceuticals(REGN.US) Officer Sells US$1.86 Million in Common Stock
$Regeneron Pharmaceuticals(REGN.US)$ Officer LAROSA JOSEPH J sold 1,865 shares of common stock on May 21, 2024 at an average price of $994.9 for a total value of $1.86 million.Source: Announcement Wha
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,855,489, According to a Recent SEC Filing
Joseph J Larosa, Executive Vice President, General Counsel and Secretary, on May 21, 2024, sold 1,865 shares in Regeneron Pharmaceuticals (REGN) for $1,855,489. Following the Form 4 filing with the SE
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Trading At A 48% Discount?
Form 144 | Regeneron Pharmaceuticals(REGN.US) Officer Proposes to Sell 470.58K in Common Stocks
SEC FILLINGS DISCLOSED/ May 21, $Regeneron Pharmaceuticals(REGN.US)$ Officer LAROSA JOSEPH J intends to sell 3,731 shares of its common stock on May 21, with a total market value of approximately $470
Regeneron Pharmaceuticals On Pace for Record High Close -- Data Talk
Regeneron Pharmaceuticals, Inc. (REGN) is currently at $995.16, up $7.89 or 0.8% --Would be new all-time high (Based on available data back to April 2, 1991) --Would be the first record close since
Regeneron Pharmaceuticals Hits 11-week High
Comments
Hello Mooers! ![]()
Recently, there have been signs that World War 3![]()
is coming (*1, *2, *3). Given the current status in the Middle East, Eastern Europe, and the Asia-Pacific, investing has become a difficult task. ![]()
In light of this hypothetical situation![]()
, I have chosen to invest from April 2024 to July 2024 using a three-pronged strategy. ![]()
![]()
![]()
Approach One: Buy the winners
Who are the winners?![]()
During wars, companies that are in the defense, oil, ...
Recently, there have been signs that World War 3
In light of this hypothetical situation
Who are the winners?
28
36
$Novavax(NVAX.US$ $Moderna(MRNA.US$
April 18, 2024
For Global Investor Audience Only
Novavax’s Nuvaxovid XBB.1.5 dispersion for injection, COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601) is now available to pharmacies across the United Kingdom (U.K.) for private healthcare providers to offer an updated protein-based non-mRNA option as part of the 2024 vaccination season.
To...
April 18, 2024
For Global Investor Audience Only
Novavax’s Nuvaxovid XBB.1.5 dispersion for injection, COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601) is now available to pharmacies across the United Kingdom (U.K.) for private healthcare providers to offer an updated protein-based non-mRNA option as part of the 2024 vaccination season.
To...
1
$Esperion Therapeutics(ESPR.US$ Esperion (ESPR) stock price has dropped from a recent high of $3.40 a share to $2.31 on FALSE claims of dilution. The price drop offers an amazing buying opportunity.
Huge News On Mar 25.2024 U.S. FDA Approved Broad Labels for NEXLIZET and NEXLETOL, now regular doctors can prescribe and Insurance will...
Huge News On Mar 25.2024 U.S. FDA Approved Broad Labels for NEXLIZET and NEXLETOL, now regular doctors can prescribe and Insurance will...
3
Morning Movers
Gapping up
$Nike(NKE.US$ stock increased by 1.4% after the sportswear company revealed its Olympic kits, aiming to leverage the appeal of top athletes to attract more consumers.
$Alpine Immune(ALPN.US$ stock surged over 36% after Vertex Pharmaceuticals announced its plan to acquire the biotech company for about $4.9 billion in cash, which would give Vertex access to a treatment for an autoimmune kidney disease.
$Rent the Runway(RENT.US$ stock ju...
Gapping up
$Nike(NKE.US$ stock increased by 1.4% after the sportswear company revealed its Olympic kits, aiming to leverage the appeal of top athletes to attract more consumers.
$Alpine Immune(ALPN.US$ stock surged over 36% after Vertex Pharmaceuticals announced its plan to acquire the biotech company for about $4.9 billion in cash, which would give Vertex access to a treatment for an autoimmune kidney disease.
$Rent the Runway(RENT.US$ stock ju...
28
🗓️ Last week’s PDUFAs:
$Akebia Therapeutics(AKBA.US$ : Approved 🎉
⇒ Vafseo (Vadadustat)
⇒ Anemia due to CKD
⇒ NDA
⇒ PDUFA: 3/27/24
$Merck & Co(MRK.US$ : Approved 🎉
⇒ WINREVAIR (sotatercept)
⇒ Pulmonary arterial hypertension
⇒ BLA
⇒ PDUFA: 3/26/24
$AstraZeneca(AZN.US$ : Approved 🎉
⇒ Ultomiris (ravulizumab)
⇒ NMOSD
⇒ sBLA
$Regeneron Pharmaceuticals(REGN.US$ : CRL 🙁
⇒ Odronextamab
⇒ r/r FL and r/r DLBCL
⇒ BLA
⇒ PDUFA: 3/31/24
📌 This week’s PDUFAs: 🚨
$AstraZeneca(AZN.US$ : 🤔
⇒...
$Akebia Therapeutics(AKBA.US$ : Approved 🎉
⇒ Vafseo (Vadadustat)
⇒ Anemia due to CKD
⇒ NDA
⇒ PDUFA: 3/27/24
$Merck & Co(MRK.US$ : Approved 🎉
⇒ WINREVAIR (sotatercept)
⇒ Pulmonary arterial hypertension
⇒ BLA
⇒ PDUFA: 3/26/24
$AstraZeneca(AZN.US$ : Approved 🎉
⇒ Ultomiris (ravulizumab)
⇒ NMOSD
⇒ sBLA
$Regeneron Pharmaceuticals(REGN.US$ : CRL 🙁
⇒ Odronextamab
⇒ r/r FL and r/r DLBCL
⇒ BLA
⇒ PDUFA: 3/31/24
📌 This week’s PDUFAs: 🚨
$AstraZeneca(AZN.US$ : 🤔
⇒...
8
4
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Money Thrill : Instead of cash (cash is ONLY an paper without underlying value ! ) I buyed Amundi PHYSICAL GOLD ETC . Friday up 0.37 % ... and in 14 days 7 %. Chinese gouvernement buyed a lot of gold! LESSON > MONEY has only a Value because the COMMON TRUST in this PAPER. [Money Printing presses can make more] On the other hand, shares also have an intrinsic value better than paper money. Then choose the right one if war breaks out
Mars MoooOP Money Thrill:
unfilteredtruths : Hold and observe. Don't buy the dip just because it's cheap. Cheap can be cheaper. Time the market (as best as you can).
Mars MoooOP unfilteredtruths:
Cui Nyonya Kueh :
View more comments...